Bayesian Sample Size Calculation in Small n, Sequential Multiple Assignment Randomized Trials (snSMART).

IF 1.3 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pharmaceutical Statistics Pub Date : 2025-01-01 DOI:10.1002/pst.2465
Fang Fang, Roy N Tamura, Thomas M Braun, Kelley M Kidwell
{"title":"Bayesian Sample Size Calculation in Small n, Sequential Multiple Assignment Randomized Trials (snSMART).","authors":"Fang Fang, Roy N Tamura, Thomas M Braun, Kelley M Kidwell","doi":"10.1002/pst.2465","DOIUrl":null,"url":null,"abstract":"<p><p>A recent study design for clinical trials with small sample sizes is the small n, sequential, multiple assignment, randomized trial (snSMART). An snSMART design has been previously proposed to compare the efficacy of two dose levels versus placebo. In such a trial, participants are initially randomized to receive either low dose, high dose or placebo in stage 1. In stage 2, participants are re-randomized to either dose level depending on their initial treatment and a dichotomous response. A Bayesian analytic approach borrowing information from both stages was proposed and shown to improve the efficiency of estimation. In this paper, we propose two sample size determination (SSD) methods for the proposed snSMART comparing two dose levels with placebo. Both methods adopt the average coverage criterion (ACC) approach. In the first approach, the sample size is calculated in one step, taking advantage of the explicit posterior variance of the treatment effect. In the other two step approach, we update the sample size needed for a single-stage parallel design with a proposed adjustment factor (AF). Through simulations, we demonstrate that the required sample sizes calculated using the two SSD approaches both provide the desired power. We also provide an applet to allow for convenient and fast sample size calculation in this snSMART setting.</p>","PeriodicalId":19934,"journal":{"name":"Pharmaceutical Statistics","volume":"24 1","pages":"e2465"},"PeriodicalIF":1.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Statistics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pst.2465","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

A recent study design for clinical trials with small sample sizes is the small n, sequential, multiple assignment, randomized trial (snSMART). An snSMART design has been previously proposed to compare the efficacy of two dose levels versus placebo. In such a trial, participants are initially randomized to receive either low dose, high dose or placebo in stage 1. In stage 2, participants are re-randomized to either dose level depending on their initial treatment and a dichotomous response. A Bayesian analytic approach borrowing information from both stages was proposed and shown to improve the efficiency of estimation. In this paper, we propose two sample size determination (SSD) methods for the proposed snSMART comparing two dose levels with placebo. Both methods adopt the average coverage criterion (ACC) approach. In the first approach, the sample size is calculated in one step, taking advantage of the explicit posterior variance of the treatment effect. In the other two step approach, we update the sample size needed for a single-stage parallel design with a proposed adjustment factor (AF). Through simulations, we demonstrate that the required sample sizes calculated using the two SSD approaches both provide the desired power. We also provide an applet to allow for convenient and fast sample size calculation in this snSMART setting.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
Pharmaceutical Statistics
Pharmaceutical Statistics 医学-统计学与概率论
CiteScore
2.70
自引率
6.70%
发文量
90
审稿时长
6-12 weeks
期刊介绍: Pharmaceutical Statistics is an industry-led initiative, tackling real problems in statistical applications. The Journal publishes papers that share experiences in the practical application of statistics within the pharmaceutical industry. It covers all aspects of pharmaceutical statistical applications from discovery, through pre-clinical development, clinical development, post-marketing surveillance, consumer health, production, epidemiology, and health economics. The Journal is both international and multidisciplinary. It includes high quality practical papers, case studies and review papers.
期刊最新文献
Introduction to qualification and validation of an immunoassay. Statistical approaches to evaluate in vitro dissolution data against proposed dissolution specifications. Synergy detection: A practical guide to statistical assessment of potential drug combinations. The partnership between statisticians and the Institutional Animal Care and Use Committee (IACUC). Potency Assay Variability Estimation in Practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1